Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Despite the current downward trend of NVO, it is a good stock to add to one's portfolio for long-term gains due to strong ...

For her first performance, Lizzo wowed in a black leather plunging bodysuit paired with silver hot pants which highlighted her slimmed-down figure. The About Damn Time hitmaker finished her look with ...

Weight loss from glucagon-like peptide 1 agonists clearly alleviates knee osteoarthritis pain, but other recently published data give pause regarding possible long-term adverse effects.

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Hims & Hers (HIMS) stock collapsed after confirming it will likely stop selling compounded weight-loss drugs ... all commercially available dosages of semaglutide from the platform.

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

Novo Nordisk rejoined the ABPI after a two-year suspension linked to promotional concerns. Audits confirmed compliance with ...

Zepbound (tirzepatide) is a prescription drug used to help with weight loss and sleep apnea in certain ... for OSA is the same as shown in this chart, except that the typical maintenance dosage ...